EudraCT Number,Sponsor Protocol Number,Sponsor Name,Full Title,Start Date,Medical condition,Disease,Population Age,Gender,Trial protocol,Link
2008-006649-18,08/0214,University College London,"CMV TCR Gene Therapy: A Phase I Safety, Toxicity and Feasibility Study of Adoptive Immunotherapy with CMV TCR-transduced Donor-derived T cells for Recipients of Allogeneic Haematopoietic Stem Cell ...",2011-11-16,"CMV reactivation/infection in post allogeneic haematopoietic stem cell transplant recipients. Allo-HSCT being performed for underlying haematological malignancy (eg, AML, ALL, NHL, Hodgkin Lymphoma...","Version: 19.0, SOC Term: 100000004865, Classification Code: 10067859, Term: Allogenic stem cell transplantation, Level: LLT",Adults,"Male, Female",GB(Prematurely Ended),https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2008-006649-18
2008-004874-42,TRAFO001,Institut für Frauengesundheit GmbH,"Evaluation of predictive Factors for the Effectivity of Aromatase Inhibitor Therapy -  Offene, prospektive, multizentrische Phase IV-Studie zur Untersuchung des Einflusses von pharmakogenetischen M...",2009-02-06,"The study examines the influence of pharmacogenetic markers on the efficacy and side effects in postmenopausal, steroid hormone positive breast cancer patients, who are treated with Letrozol. The p...","Version: 20.0, SOC Term: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps), Classification Code: 10006187, Term: Breast cancer, Level: PT","Adults, Elderly",Female,DE(Ongoing),https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2008-004874-42
2008-002768-32,MM03,Freistaat Bayern,"A prospective phase I/II, one-arm, one-stage multi-center, open label study of lenalidomide in combination with pioglitazone, dexamethasone and metronomic low-dose chemotherapy with treosulfan in p...",2009-06-08,Multiple myeloma,"Version: 21.0, SOC Term: 100000004864, Classification Code: 10028228, Term: Multiple myeloma, Level: LLT","Adults, Elderly","Male, Female",DE(Completed),https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2008-002768-32
2010-022400-53,NLH-01,Køge Hospital,Intracoronary administration of melatonin for patients with acute myocardial infarction: a placebo controlled randomized study.,2011-01-13,Acute Myocardial Infarction,"Version: 18.1, SOC Term: 10007541 - Cardiac disorders, Classification Code: 10000891, Term: Acute myocardial infarction, Level: PT","Adults, Elderly","Male, Female",DK(Completed),https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2010-022400-53
2008-003174-18,PACET-CUP,Universitätsklinikum Heidelberg,"Open-labeled, randomized multi-center phase II study evaluating the efficacy and safety of Paclitaxel/ Carboplatin with and without Cetuximab as first-line treatment of adeno- and undifferentiated ...",2009-12-18,adeno- and undifferentiated Carcinoma of Unknown Primary (CUP),,"Adults, Elderly","Male, Female",DE(Completed),https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2008-003174-18
2006-001095-21,A5I16,Sanofi Pasteur Inc.,"Immunogenicity and Safety of PEDIACEL®, a Combined Diphtheria, Tetanus, Five Component Acellular Pertussis, Inactivated Poliomyelitis and Haemophilus influenzae Type b Conjugate Vaccine (Adsorbed),...",2016-04-19,"Pertussis, adsorbed diphtheria and tetanus toxoids, inactivated poliomyelitis and polysaccharide of H. influenza type b bound to tetanus toxoid",,"Infants and toddlers, Under 18","Male, Female",Outside EU/EEA,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2006-001095-21
2006-000653-22,GART1013,Moorfields Eye Hospital,The UK Glaucoma Treatment Study,2006-07-26,Primary open-angle Glaucoma Pseudoexfoliation Glaucoma,"Version: 20.0, SOC Term: 100000004853, Classification Code: 10037118, Term: Pseudoexfoliation glaucoma, Level: LLT","Adults, Elderly","Male, Female",GB(Completed),https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2006-000653-22
2008-000581-23,CSPP100A2244,Novartis Pharma AG,"A randomized, double-masked, placebo-controlled add on study to assess the efficacy of oral aliskiren 300 mg once daily for diabetic macular edema",2008-07-28,Diabetic Macular Edema (DME) in hypertensive patients,"Version: 19.0, SOC Term: 100000004853, Classification Code: 10057915, Term: Diabetic macular oedema, Level: LLT","Adults, Elderly","Male, Female",DK(Completed),https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2008-000581-23
2007-001058-16,V00147GL202,PIERRE FABRE MEDICAMENT,A PHASE II DOUBLE-BLIND VEHICLE-CONTROLLED CROSSOVER SINGLE DOSE (400 µG) V0147 GEL EFFECT AND TOLERANCE STUDY IN SPINAL CORD INJURED PATIENTS WITH ERECTILE DYSFUNCTION,2007-04-30,Erectile dysfunction,"Version: 21.1, SOC Term: 10038604 - Reproductive system and breast disorders, Classification Code: 10052004, Term: Organic erectile dysfunction, Level: PT",Adults,Male,FR(Prematurely Ended),https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2007-001058-16
2008-007225-39,CareRA,University Hospitals Leuven,A 2 year prospective multicentre randomised controlled trial comparing effectiveness in daily practice of different treatment strategies for early RA,2009-01-06,"early active Rheumatoid Arthritis, previously untreated with DMARDS","Version: 20.0, SOC Term: 10028395 - Musculoskeletal and connective tissue disorders, Classification Code: 10039073, Term: Rheumatoid arthritis, Level: PT","Adults, Elderly","Male, Female",BE(Completed),https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2008-007225-39
2010-023062-40,PRP-001,"Medivation, Inc.","A Phase 1/2, First in Human, Single-arm, Open-label Study of Once a Day, Orally Administered Talazoparib (BMN 673) in Patients with Advanced or Recurrent Solid Tumors",2011-04-19,Advanced or recurrent solid tumors for which there is no accepted standard treatment or for which standard treatment has failed.  Patients may also be eligible if they are unable or decline to unde...,"Version: 19.0, SOC Term: 100000004864, Classification Code: 10065147, Term: Malignant solid tumor, Level: LLT","Adults, Elderly","Male, Female",GB(Completed),https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2010-023062-40
2009-016877-14,H1N1-2009,COPSAC,H1N1v Vaccination of Pregnant Women: A Longitudinal Cohort Study Characterizing Influenza A-H1N1v Vaccination in Pregnant Women,2009-11-04,Protection against Influenza A H1N1v disease,,"In utero, Preterm newborn infants, Newborns, Infants and toddlers, Under 18, Adults","Male, Female",DK(Completed),https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2009-016877-14
2011-002044-28,HGT-MLD-070,Shire Human Genetics Therapies Inc,"A Phase I/II, Multicenter, Open-label, Dose Escalation Study of HGT-1110 Administered Intrathecally in Children with Metachromatic Leukodystrophy",2012-06-14,Treatment of Metachromatic Leukodystrophy,"Version: 19.0, SOC Term: 10010331 - Congenital, familial and genetic disorders, Classification Code: 10067609, Term: Metachromatic leukodystrophy, Level: PT","Infants and toddlers, Children, Under 18","Male, Female",DE(Completed) DK(Completed),https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2011-002044-28
2013-001048-73,BAY41-6551/13084,Bayer AG,"A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of BAY 41-6551 as Adjunctive Therapy in Intubated and Mechanically-Ventilated Pati...",2013-07-25,Gram-negative pneumonia,"Version: 19.0, SOC Term: 100000004862, Classification Code: 10035701, Term: Pneumonia gram-negative bacterial NOS, Level: LLT","Adults, Elderly","Male, Female",CZ(Completed),https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2013-001048-73
2012-001650-26,AnticholiumperSeIII,"Ruprecht-Karls-University Heidelberg, Med Faculty represented by Universitätsklinikum Heidelberg and its Commercial D","A randomised, placebo-controlled, double-blind, monocentre study on the application of physostigminsalicylate (Anticholium®) as adjunctive measure in perioperative sepsis/septic shock",2014-04-28,,"Version: 19.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10040047, Term: Sepsis, Level: PT","Adults, Elderly","Male, Female",DE(Completed),https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2012-001650-26
2012-000447-27,USKH_VL1,"Universitätsklinikum Schleswig-Holstein, Campus Kiel",Open Label Study for the Functional Characterization of Drug Metabolism and Transport in patients before routine visceral surgery,2012-07-25,"Pharmacokinetic trial in patients, with a good general condition before standard abdominal surgery",,"Adults, Elderly","Male, Female",DE(Temporarily Halted),https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2012-000447-27
2012-000449-11,EP250567,Eero Pesonen,Heparin dose (300 IU/kg vs. 600 IU/kg) in coroanry artery bypass grafting,2012-03-01,Patients undergoing elective coronary artery bypass grafting,"Version: 21.1, SOC Term: 100000004865, Classification Code: 10068176, Term: Coronary artery bypass graft, Level: LLT","Adults, Elderly","Male, Female",FI(Ongoing),https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2012-000449-11
2011-005066-38,CINC424AGB02,Novartis Pharmaceuticals UK Ltd,"A UK open-label, multicentre, exploratory Phase II study of INC424 for patients with primary myelofibrosis (PMF) or post polycythemia myelofibrosis (PPV MF) or post-essential thrombocythemia myelof...",2012-03-09,"primary myelofibrosis (PMF), post polycythemia vera myelofibrosis (PPV MF) or Post essential thrombocythemia myelofibrosis (PET-MF)",,"Adults, Elderly","Male, Female",GB(Completed),https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2011-005066-38
2011-005082-21,Uni-Koeln-1491,University of Cologne,Targeted BEACOPP variants in patients with newly diagnosed advanced classical Hodgkin Lymphoma,2012-09-25,newly diagnosed advanced classical Hodgkin Lymphoma,"Version: 20.0, SOC Term:  100000004851, Classification Code: 10025319, Term: Lymphomas Hodgkin's disease, Level: HLGT",Adults,"Male, Female",DE(Completed),https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2011-005082-21
2012-004439-22,CAIN457F2312,Novartis Pharma Services AG,"A Phase III randomized, double-blind, placebo-controlled multicenter study of subcutaneous secukinumab in prefilled syringes to demonstrate the efficacy at 24 weeks and to assess the long term effi...",2013-04-08,Psoriatic arthritis,"Version: 19.1, SOC Term: 100000004859, Classification Code: 10037160, Term: Psoriatic arthritis, Level: LLT","Adults, Elderly","Male, Female",GB(Completed) BE(Completed) CZ(Completed) DE(Completed) PL(Completed),https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2012-004439-22
